Search results
Author(s):
Kevin Cheng
,
Jonathan M Hill
,
Ranil de Silva
Added:
1 year ago
Author(s):
Robert Jay Widmer
Added:
2 months ago
In this 'Cath Lab Guide to Coronary Reactivity Testing', Dr Robert Jay Widmer (The McKinney Heart Hospital, US) turns the focus to thermodilution-based coronary physiology, employing both intracoronary and intravenous adenosine. He demonstrates step-by-step measurement of resting and hyperaemic transit times, distal coronary pressure, and the calculation of fractional flow reserve (FFR), coronary…
View more
Coronary Reactivity Testing for Non‑Obstructive CAD
Video Series
Author(s):
Robert Jay Widmer
Added:
2 months ago
In this segment of the 'Cath Lab Guide to Coronary Reactivity Testing', Dr Robert Jay Widmer (The McKinney Heart Hospital, US) demonstrates an intracoronary acetylcholine protocol using low-dose (20µg) and higher-dose (100µg) infusions. He outlines preparation of the solution from ophthalmic vials, its dilution, and the technique for slow intra-coronary injection over 1–2 minutes.Dr Widmer…
View more
Author(s):
Robert Jay Widmer
Added:
2 months ago
Welcome to the introductory segment of Dr Robert Jay Widmer's 'Cath Lab Guide to Coronary Reactivity Testing in Non‑Obstructive CAD'.Dr Widmer (The McKinney Heart Hospital, US) presents the case of a 25-year-old female endurance runner experiencing exertional, band-like chest pain. Her coronary CTA appears normal, while PET imaging reveals mildly reduced flow confined to the circumflex territory…
View more
Added:
10 months ago
Source:
Radcliffe Cardiology
For patients with suspected angina with non-obstructive coronary arteries (ANOCA) or ischaemia with non-obstructive coronary arteries (INOCA), the diagnostic pathway can be challenging. A new study suggests that while exercise electrocardiography stress testing (EST) has limited ability to confirm underlying microvascular disease, its high negative predictive value makes it a valuable tool for…
View more
Author(s):
Nicolas M Van Mieghem
Added:
4 weeks ago
In this EuroPCR 2026 preview, Prof Nicolas Van Mieghem (Erasmus University, NL) walks through the most anticipated late-breaking trials across calcified coronary disease, structural heart intervention, and mechanical support — from laser-based IVL and atherectomy comparisons to three-year TAVI outcomes, tricuspid repair, high-risk PCI, and pulmonary embolism therapy.Editor: Mirjam Boros
View more
Michael C Gibson
Research Area(s) / Expertise:
Job title: CEO non-profit Baim / PERFUSE Research Institute, Harvard Professor, Cardiologist BIDMC, Founder & Chairman WikiDoc.org
Author
Tessel Vossenberg
Research Area(s) / Expertise:
Author
Author(s):
Ankur Kalra
,
Nicolas M Van Mieghem
,
Roxana Mehran
Added:
2 months ago
In this special TIO Congress edition of Parallax, Dr Ankur Kalra is joined by two of interventional cardiology's most influential voices: Professor Roxana Mehran, incoming President of the American College of Cardiology and Co-Course Director of TIO, and Professor Nicholas Van Mieghem, TIO Course Director. The conversation spans the evolution of online medical education, sex-specific differences…
View more